The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
Related Posts
As Trump Courts a More Assertive Beijing, China Hawks Are Losing Out
The Trump administration has dialed back aggressive measures against China and reversed its position on technology controls as the president…
Boeing and Union for 3,200 Striking Workers Reach New Proposed Deal
Workers who make military aircraft and equipment in the St. Louis area have been on strike since early August after…
Can the World Cup Help the U.S. Beer Industry Kick Its Slump?
Bars and stores are uncertain if the soccer tournament will boost beer sales. Still, the maker of Budweiser and Michelob…